logo
Remote Hiring 2.0: Scaling Your Talent Pipeline With AI And Keeping It Authentic

Remote Hiring 2.0: Scaling Your Talent Pipeline With AI And Keeping It Authentic

Forbes3 days ago
Ruben Vardanyan is founder & CEO of Joomag, helping companies craft immersive, measurable digital content experiences.
Remote roles still command roughly one-quarter of U.S. professional job postings, six times the pre-pandemic share. To keep pace, 73% of talent-acquisition leaders say artificial intelligence will reshape hiring within the next two years.
That same technology, however, now powers sophisticated fraud. In a March 2025 survey, 76% of hiring managers said AI makes it harder to confirm that applicants are authentic. Financial regulators echo the warning: A 2024 FinCEN alert details deepfake identity documents designed to slip past customer-verification checks.
I experienced the collision firsthand when a supposedly L.A.-based marketing candidate froze during a quick webcam flip. The image was an AI avatar; the real person was thousands of miles away. That moment cemented a new reality: Leaders must harness AI to speed hiring while simultaneously verifying authenticity across all functions, from marketing to finance to customer success.
The Double-Edged Sword Of AI In Hiring
AI accelerates sourcing, CV screening and scheduling. LinkedIn's new 'hiring assistant' can draft job posts, find candidates and personalize outreach, yet those same generative tools let applicants auto-tailor CVs and consult ChatGPT in real time.
Without safeguards, companies risk onboarding sales reps who can't pitch, analysts who can't reconcile a spreadsheet and designers who have never opened Figma. The fix is not to retreat from AI, but to engineer trust into the process.
A Three-Layer Framework For Fraud-Resistant, High-Velocity Hiring
Begin with automated digital-footprint scoring. Software can scan a candidate's LinkedIn history for multi-month activity, consistent job timelines and meaningful engagement. At my company, where a single posting can draw 5,000 applicants, this filter alone removes roughly 40% of submissions in under 30 minutes.
If a marketing lead shows no public content or a finance applicant's entire network appeared only last week, route that person to heightened ID checks. Next, seek cross-platform corroboration by matching CV claims against GitHub commits, conference presentations or published slide decks. Authentic public behavior is still hard to fake at scale, so these signals eliminate most synthetic profiles before any human conversation begins.
The second layer relies on AI to test both competence and authenticity in real time. An adaptive chatbot generates tailored questions, increases complexity when answers are strong and inserts surprise 'prove-you-are-live' tasks such as screen-sharing, writing a short SQL query or sketching a customer-journey map. Behind the scenes, the system tracks response latency and keystroke cadence; consistent pauses after every prompt often reveal someone consulting ChatGPT on a second monitor.
Since deploying this stage, our talent team reduced average time-to-shortlist from nine days to 48 hours and cut spend by 31%. Role-specific exercises keep the assessment relevant: A sales candidate records a 90-second cold pitch, a designer edits a Figma file live and a finance analyst reconciles a mini P&L on screen. The AI flags only those who clear both skill and integrity bars for the next round.
With identity and baseline competence verified, the last step is a panel conversation focused on judgment, culture fit and long-term potential. Interviewers can now dig deep: 'Describe a time you missed a deadline and how you reset stakeholder expectations,' or 'Our road map just shrank by 20%; which projects would you drop first, and why?' Because few original applicants reach this point, hiring managers can reserve their energy for the nuanced, high-value conversations that determine true fit.
Each finalist also arrives with an AI-generated dossier, concise notes that distill their responses, aptitude metrics and integrity signals, so managers start informed and move faster. The net result: We now fill roles in under 30 days, compared with the months-long cycles we endured before the framework went live.
Implementation Best Practices
• Track everything. Track false-positive and false-negative fraud flags, time-to-offer, 90-day retention and recruiter hours saved.
• Be transparent. Tell applicants that AI integrity tools are in play. Honest candidates appreciate the clarity, while fraudsters often self-select out.
• Red-team your funnel. Every quarter, ask internal staff to 'cheat' with the latest AI tools and patch gaps the exercise reveals.
• Audit for bias. Review rejection patterns by gender, age and geography; retrain models that over-penalize non-native accents or slower typists.
• Demand vendor openness. Require documentation of bias testing and the right to inspect raw logs during investigations.
The Leadership Takeaway
Remote work unlocked global talent, and generative AI unlocked global imitation. Firms that verify first, automate smartly and humanize last gain durable advantages. Deepfake or AI-scripted fraud gets caught before it reaches payroll, protecting data, culture and brand. In an era where a convincing CV can be faked in 30 seconds and a realistic avatar in minutes, engineering trust as a measurable datapoint is the fastest route to hiring smarter across every function of the organization.
Forbes Business Council is the foremost growth and networking organization for business owners and leaders. Do I qualify?
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Did anyone win Powerball drawing last night, Aug. 2, 2025? Winning numbers, jackpot results
Did anyone win Powerball drawing last night, Aug. 2, 2025? Winning numbers, jackpot results

Yahoo

time19 minutes ago

  • Yahoo

Did anyone win Powerball drawing last night, Aug. 2, 2025? Winning numbers, jackpot results

The Powerball lottery jackpot continues to grow after no one matched all six numbers from Wednesday night's drawing. Grab your tickets and check your numbers to see if you're the game's newest millionaire. Here are the numbers for Saturday, Aug. 2, Powerball jackpot worth an estimated $410 million with a cash option of $186.2 million. Winning Powerball numbers tonight: Aug. 2, 2025 Saturday night's drawing will take place at 10:59 p.m. ET. The winning numbers for Wednesday night's drawing were 4, 15, 35, 50, 64, and the Powerball is 8. The Power Play was 4X. Powerball, Mega Millions: Want to win the lottery? Here are luckiest numbers, places to play Who won Powerball drawing jackpot tonight, 8/2/25? Did anyone match Powerball numbers last night? Lottery results Results are pending. Powerball winner? Lock up your ticket and go hide. What to know if you win the jackpot How many Powerball numbers do you need to win a prize payout? You only need to match one number in Powerball to win a prize. However, that number must be the Powerball worth $4. Visit for the entire prize chart. What is the Powerball payout on matching 2 lottery numbers? Matching two numbers won't win anything in Powerball unless one of the numbers is the Powerball. A ticket matching one of the five numbers and the Powerball is also worth $4. Visit for the entire prize chart. Powerball numbers you need to know: These most commonly drawn numbers could help you win How much is the Powerball drawing jackpot 8/2/25? The Powerball jackpot for Saturday, Aug. 2, 2025, grows to an estimated $410 million with a cash option of $186.2 million, according to What time is the next Powerball drawing? What are draw days? Drawings are held three times per week at approximately 10:59 p.m. ET every Monday, Wednesday, and Saturday. How much is a Powerball lottery ticket today? A single Powerball ticket costs $2. Pay an additional $1 to add the Power Play for a chance to multiply all Powerball winnings except for the jackpot. Players can also add the Double Play for one more $1 to have a second chance at winning $10 million. How to play Powerball today Mega Millions numbers: Anyone win Friday night's drawing? Winning Mega Millions numbers 8/1/25 Friday night's winning numbers were 18, 27, 29, 33, 70, and the Mega Ball was 22. How much is the Mega Millions drawing jackpot on 8/5/25? The Mega Millions jackpot for Tuesday's drawing grows to an estimated $150 million with a cash option of $67.9 million after no Mega Millions tickets matched all six numbers to win the jackpot, according to 2025 Powerball jackpot winners Here is the list of 2025 Powerball jackpot wins, according to $328.5 million — Jan. 18; Oregon. $526.5 million — March 29; California $167.3 million — April 26; Kentucky. $204.5 million — June 1; California. Powerball Top 10 lottery drawing jackpot results Here are the all-time top 10 Powerball jackpots, according to $2.04 billion — Nov. 7, 2022; California. $1.765 billion — Oct. 11, 2023; California. $1.586 billion — Jan. 13, 2016; California, Florida, Tennessee. $1.326 billion — April 6, 2024; Oregon. $1.08 billion — July 19, 2023; California. $842 million — Jan. 1, 2024; Michigan. $768.4 million — March 27, 2019; Wisconsin. $758.7 million — Aug. 23, 2017; Massachusetts. $754.6 million — Feb. 6, 2023; Washington. $731.1 million — Jan. 20, 2021; Maryland. Powerball numbers: Anyone win Wednesday night's drawing? Powerball, Mega Millions history: Top 10 U.S. lottery drawing jackpot results Here are the nation's all-time top 10 Powerball and Mega Millions jackpots, according to $2.04 billion, Powerball — Nov. 7, 2022; California. $1.765 billion, Powerball — Oct. 11, 2023; California. $1.586 billion, Powerball — Jan. 13, 2016; California, Florida, Tennessee. $1.58 million, Mega Millions — Aug. 8, 2023; Florida. $1.537 billion, Mega Millions — Oct. 23, 2018; South Carolina. $1.35 billion, Mega Millions — Jan. 13, 2023; Maine. $1.337 billion, Mega Millions — July 29, 2022; Illinois. $1.326 billion, Powerball — April 6, 2024; Oregon $1.22 billion, Mega Millions — Dec. 27, 2024; California. $1.13 billion, Mega Millions — March 26, 2024; New Jersey. Chris Sims is a digital content producer at Midwest Connect Gannett. Follow him on Twitter: @ChrisFSims. This article originally appeared on Indianapolis Star: Powerball Aug. 2, 2025: Winning numbers, drawing time, lottery results Solve the daily Crossword

Unemployed Americans Endure Longer Job Searches in a Cooling Market
Unemployed Americans Endure Longer Job Searches in a Cooling Market

Wall Street Journal

time21 minutes ago

  • Wall Street Journal

Unemployed Americans Endure Longer Job Searches in a Cooling Market

Job seekers are out in the cold this summer. Especially the ones who have been hunting for a while. Beyond the headline-grabbing top-line numbers in the jobs report for July was another striking piece of data: The number of people unemployed for at least 27 weeks topped 1.8 million, the highest level since 2017, not counting the pandemic's unemployment surge. The median length of unemployment in the U.S. has also ticked up, from a seasonally adjusted 9.5 weeks in July 2024 to 10.2 weeks last month.

Trump Says He Will Get Drug Prices Down By 1500%
Trump Says He Will Get Drug Prices Down By 1500%

Forbes

time21 minutes ago

  • Forbes

Trump Says He Will Get Drug Prices Down By 1500%

U.S. President Donald Trump is now promising to get pharmaceutical companies to significantly reduce the drug prices that they are charging Americans. On Thursday, the White House announced that Trump had just sent letters to the heads of 17 major pharmaceutical companies pushing them to cut the prices that Americans have to pay down to the levels that people in other countries pay. It's not clear yet by what amount—if any—this will eventually get pharmaceutical companies to reduce prescription medication prices for those in the U.S. But chances are any price reductions that end up occurring won't be anywhere near the 1500% that Trump has promised. Trump Spoke Of 600%, 1000% And 1500% Reductions in Drug Prices Yep, 1500% is the percentage that Trump mentioned in a July reception with members of Congress. 'This is something that nobody else can do,' Trump emphasized then. "We're gonna get the drug prices down. Not 30 or 40 percent, which would be great, not 50 or 60, no. We're gonna get 'em down 1,000 percent, 600 percent, 500 percent, 1,500 percent.' Here's a video of this posted on what used to be Twitter: Getting the prices of medications—or of anything that's sold by companies for that matter—down by more than 100% is certainly something that no one else has done. It's probably something you have never even dreamed of before, since for-profit companies are usually trying to make, you know, a profit. So, it's kind of true what Trump then subsequently said, 'We will have reduced drug prices by 1,000 percent, by 1,100, 1,200, 1,300, 1,400, 700, 600; not 30 or 40 or 50 percent but numbers the likes of which you've never even dreamed of before.' A video of this was also posted on X: Let's do the math. Say a bottle of a medication currently costs $100. A 25% price reduction would bring this cost down to $75. A 100% price reduction would make the medication completely free. Any reduction greater than 100% would presumably mean that the manufacturer would have to pay you. Thus, a 200% price reduction would result in a $100 payday per bottle for you. Holy, new way to earn money, Batman! If Trump can get you a 1500% reduction, hallelujah, time to replace filming YouTube videos with 'buying' medications as the way to make money. Now, the chances that the Trump administration will achieve a 1500% reduction in drug prices are probably a whole lot less than 100%. Getting pharmaceutical companies who have been enjooying very healthy profits for years to pay customers to take their drugs would be quite a trick. Plus, the pharmaceutical companies would have to change their advertisements so that instead of telling you that you may have a condition that you don't realize you have, the ads might say something like 'You're fine and don't have anything that pharmaceutical interventions can't fix. Please don't use our medications. We can't afford you to do so.' Trump Sent Letters To 17 Pharmaceutical Companies Outlining Steps To Reduce Drug Prices That 1500% number may not have been in the letters that Trump sent on Thursday to pharmaceutical manufacturers. Assuming that the letters had the right postage, they went to the leaders of AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, EMD Serono, Genentech, Gilead, GSK, Johnson & Johnson, Merck, Novartis, Novo Nordisk, Pfizer, Regeneron and Sanofi. According to the White House, the letters listed steps to reduce the prices of prescription drugs in the U.S. 'to match the lowest price offered in other developed nations (known as the most-favored-nation, or MFN, price)' The steps are as follows: The letters asserted that there's been 'global freeloading on American pharmaceutical innovation' and did warn that if the outlined steps were't taken by the pharmaceutical companies the federal government "will deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices." Trump Signed An Executive Order Regarding Drug Prices In May Pharmaceutical companies can now be 1500% sure that the Trump administration has them in its political line-of-sight. Back on May 12, Trump signed an Executive Order that asserted the following: 'The United States has less than five percent of the world's population and yet funds around three quarters of global pharmaceutical profits. This egregious imbalance is orchestrated through a purposeful scheme in which drug manufacturers deeply discount their products to access foreign markets, and subsidize that decrease through enormously high prices in the United States.' That Executive Order indicated that the U.S. Secretary of Health and Human Services, which is currently Robert F. Kennedy, Jr., 'shall facilitate direct-to-consumer purchasing programs for pharmaceutical manufacturers that sell their products to American patients at the most-favored-nation price.' Americans Do Pay Higher Drug Prices Than Those In Other Countries It is true that drug prices are typically significantly higher in the U.S. than in other countries. For example, a June 2024 publication in the RAND Health Quarterly described how drug prices in the U.S. were on average nearly three times higher than those in 33 other high-income countries. Over the past two decades, yearly rises in drug prices have easily outpaced inflation. A 2024 KFF poll showed that the majority of Americans are worried about prescription medication costs being too high. Such worries shouldn't be that surprising. Many prescription medications are not like mullets or fruitcakes. Taking them is often not a choice. Your well-being and even your life could literally depend on being able to afford the medication. And many pharmaceutical companies have shown no qualms about raising the price of medications as soon as they can. For example, even after receiving substantial funding from the U.S. government, Pfizer and Moderna quickly raised the prices of their COVID-19 vaccines as soon as the government wouldn't completely pay for them, as I described in Forbes in 2023. It is also true that talk about drug prices being too high in the U.S. is not new. Yet, none of the Presidential Administrations over the past two decades have done much to significantly alter these trends. I've written about state-wide efforts to reduce drug prices, such as Propostion 61 in California. But there's been a lack of more comprehensive efforts at the federal level to do so. The challenge is that a number of trends in the current U.S. system are contributing to higher drug prices. For example, mergers and acquisitions over the years have led to fewer, larger and more dominant pharmaceutical companies with less competition. Existing cost structures and requirements make it more difficult for new pharmaceutical companies to emerge and provide more competition. Cuts in funding and support for scientific research has made it harder and harder to develop new products. Fewer new products leave patients with fewer alternatives and existing products with less competition. Consumers and different purchasers have lacked negotiating power in general. At the same time, it seems like more and more people have been getting pieces of the drug price pie. This has included various middle people such as pharmacy benefits managers and different administrators. The marketing budgets of pharmaceutical companies have continued to grow as well. On top of that, investors have expected pharmaceutical companies to have ever increasing profitability. All of this means that a single simple intervention probably has a small percentage chance of reducing drug prices in a sustainable manner. Instead, a system approach may be needed, meaning multiple interventions at different points in the system that work together in a coordinated manner. Otherwise, there may be unintended consequences. A sustainable reduction in drug prices means one in which the math works out for all patients. You don't want a situation where the prices of some drugs are reduced while those of others are raised. You also don't want a situation where the costs end up being hidden.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store